
BURLINGTON, Mass., Jan. 23, 2025 — Azenta, Inc. (Nasdaq: AZTA) announced that UK Biocentre selected its technology to expand its large-scale sample storage for internationally significant collections. This complements seven existing Azenta BioArc™ Flex™ systems. The new BioArc Ultra™ system will support crucial research projects, including the United Kingdom’s Our Future Health program.
The BioArc Ultra will be installed in UK Biocentre’s 70,000-square-foot Milton Keynes, England facility. Currently storing over 35 million samples, the facility will increase capacity by 16 million samples with the BioArc Ultra’s high-density, fully automated -80°C storage and up to 9 million sample retrievals annually. UK Biocentre uses Azenta’s automated systems and FluidX™ 2D-coded tubes to enhance inventory management, reduce variability, and mitigate risks.
The Ultra offers operational efficiencies, including reduced space, labor, and energy costs compared to other systems. Its eco-friendly refrigeration system aligns with UK Biocentre’s sustainability goals, boasting zero Ozone Depletion Potential and zero Global Warming Potential. The system allows for up to 10 picking stations, offering flexibility in throughput and labware.
UK Biocentre will leverage the BioArc Ultra’s capacity to support the UK’s Our Future Health study of up to 5 million people, aiming to develop disease prevention, detection, and treatment methods.
Dr. Tony Cox OBE, UK Biocentre’s CEO, stated, “The BioArc Ultra keeps UK Biocentre at the forefront of sample storage, minimizing the environmental impact of research. We’re pleased to partner with Azenta Life Sciences to bring this to the UK, maximizing sample potential.”
“We’re excited to support UK Biocentre with the BioArc Ultra’s advanced automation,” said Alex Esmon, Azenta Life Sciences’ Vice President and General Manager of Global Products. “The BioArc Ultra enables faster breakthroughs through improved automation and refrigeration technology, ensuring sample integrity, streamlining workflows, and promoting sustainability.”
To learn more about the BioArc Ultra, visit .
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading global provider of life sciences solutions, accelerating breakthroughs and therapies. Azenta offers comprehensive cold-chain sample management and multiomics services for drug development, clinical research, and advanced cell therapies, serving top pharmaceutical, biotech, academic, and healthcare institutions worldwide. Our global team supports these offerings through brands including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit .
About the UK Biocentre
UK Biocentre is a leader in sample management, high-capacity bioprocessing & analysis, and automated storage. We support large-scale biomedical, pharmaceutical, and clinical studies, enabling research advancements in academia, pharmaceuticals, and biotech. We provide reliable, high-quality solutions using state-of-the-art technology and adhering to high compliance standards. For more information, please visit .
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial, Planning & Analysis and Investor Relations
PUBLIC RELATIONS CONTACT:
Renay Picard
Director of Marketing, Sample Management Solutions
SOURCE Azenta